Vaccines
A series of five cases of Herpes Zoster occurring after vaccination with a nucleoside-modified messenger RNA (mRNA) COVID-19 vaccine has been reported by researchers at the Hospital Center University of Lille. The cases do not establish causality between COVID-19 vaccination and Herpes Zoster, but local vaccine-induced immunomodulation may be involved.
Vaccines
Alnylam Pharmaceuticals has filed a lawsuit in the United States District Court for the District of Delaware against Pfizer and Moderna, accusing them of patent infringement related to the development of COVID-19 vaccines using messenger RNA (mRNA) technology. The patent in question, US Patent No. 11,246,933, relates to
Vaccines
Two years into the COVID-19 pandemic, the world is witnessing enormous scientific advances in developing vaccines and treatments. However, access to these life-saving technologies remains vastly unequal, with more than a third of the global population yet to be vaccinated and low-income countries struggling to access treatments. The patent protections
Vaccines
The healthcare distribution market has emerged as a vital sector during the COVID-19 pandemic, driven by the increasing demand for medical supplies, pharmaceuticals, and vaccines. The market is expected to witness tremendous growth, outpacing other sectors due to the pandemic's impact on global healthcare systems. Key Takeaways: * The
Vaccines
The Biden administration secretly funded a $1 billion propaganda campaign to promote COVID-19 vaccines while censoring negative information, revealed in a Freedom of Information Act (FOIA) request filed by Blaze Media. The scheme involved paying hundreds of news organizations to advertise for the shots, including ABC, CBS, NBC, Fox News,
Vaccines
Evonik Industries AG, a leading specialty chemicals company, has announced a significant expansion of its plant-derived cholesterol production in Hanau, Germany. This move aims to meet the growing demand for PhytoChol(r), a critical component used in lipid nanoparticles (LNPs) for COVID-19 vaccines and other mRNA-based therapeutics. The increased supply
Vaccines
Researchers from the University of Florida have published a new report on the FDA approval of the Pfizer-BioNTech COVID-19 vaccine, highlighting its high efficacy in preventing infection. The study found that the vaccine was 91.1% effective in preventing COVID-19 cases in individuals 16 years or older without prior evidence
Pharmaceutical industry
The global orphan drugs market reached a value of $168.9 Billion in 2021, driven by the increasing prevalence of cancer and other rare genetic disorders, as well as the development of innovative orphan drugs to provide personalized therapy to patients. The market is expected to reach $342.4 Billion
Pharmaceutical industry
The World Health Organization (WHO) has announced the creation of a global training center in South Korea to help poorer countries develop mRNA vaccines, antibodies, and cancer treatments using the technology that has successfully been used to make COVID-19 vaccines. The hub, which will share mRNA technology being developed by
Pharmaceutical industry
Investment firm AXS Investments, LLC has filed with the SEC to introduce a series of double-leveraged exchange-traded funds (ETFs) that track the performance of individual U.S.-listed equity securities. Each fund aims to provide daily returns twice that of the underlying security, offering a unique investment opportunity for traders
Pharmaceutical industry
The Atopic Dermatitis market is expected to witness significant growth in the coming years, driven by the emergence of new and innovative therapies, increased awareness, and improved access to healthcare services. A recent report by DelveInsight Business Research, LLP highlights the potential launch of several new therapies, including Abrocitinib/PF-04965842,
Pharmaceutical industry
The global Alzheimer drugs market is expected to grow significantly, driven by the rising prevalence of Alzheimer's disease and advancements in telehealth services. The market was valued at USD 6537.0 Million in 2021 and is anticipated to reach USD 6537.0 Million by the end of 2027,
